Home/Filings/4/0001179110-21-005850
4//SEC Filing

Shafer Bradford J 4

Accession 0001179110-21-005850

CIK 0001583107other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 6:18 PM ET

Size

4.7 KB

Accession

0001179110-21-005850

Insider Transaction Report

Form 4
Period: 2021-05-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2021-05-20$17.80/sh4,310$76,718282,138 total
Footnotes (1)
  • [F1]Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001302448

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 6:18 PM ET
Size
4.7 KB